JP2007518732A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518732A5
JP2007518732A5 JP2006548383A JP2006548383A JP2007518732A5 JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5 JP 2006548383 A JP2006548383 A JP 2006548383A JP 2006548383 A JP2006548383 A JP 2006548383A JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5
Authority
JP
Japan
Prior art keywords
polymer
organisms
complex
pathogenic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006548383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518732A (ja
Filing date
Publication date
Priority claimed from GBGB0400264.8A external-priority patent/GB0400264D0/en
Application filed filed Critical
Publication of JP2007518732A publication Critical patent/JP2007518732A/ja
Publication of JP2007518732A5 publication Critical patent/JP2007518732A5/ja
Pending legal-status Critical Current

Links

JP2006548383A 2004-01-07 2005-01-07 アジュバント活性を有する複合体 Pending JP2007518732A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0400264.8A GB0400264D0 (en) 2004-01-07 2004-01-07 Complexes
PCT/GB2005/000039 WO2005065712A2 (en) 2004-01-07 2005-01-07 Complexes having adjuvant activity

Publications (2)

Publication Number Publication Date
JP2007518732A JP2007518732A (ja) 2007-07-12
JP2007518732A5 true JP2007518732A5 (https=) 2008-02-07

Family

ID=31503533

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006548383A Pending JP2007518732A (ja) 2004-01-07 2005-01-07 アジュバント活性を有する複合体

Country Status (10)

Country Link
US (1) US20090176866A1 (https=)
EP (1) EP1701741B1 (https=)
JP (1) JP2007518732A (https=)
CN (1) CN1909928B (https=)
AT (1) ATE396742T1 (https=)
AU (1) AU2005203908B2 (https=)
DE (1) DE602005007177D1 (https=)
ES (1) ES2308432T3 (https=)
GB (1) GB0400264D0 (https=)
WO (1) WO2005065712A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316294D0 (en) * 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
GB0722080D0 (en) * 2007-11-09 2007-12-19 Polytherics Ltd Novel complexes and a process for their preparation
WO2010006454A2 (en) 2008-06-30 2010-01-21 Esbatech, An Alcon Biomedical Research Unit Llc Functionalized polypeptides
MX2011000009A (es) 2008-07-10 2011-08-15 Esbatech Alcon Biomed Res Unit Metodos y composiciones para la administracion mejorada de macromoleculas.
GB201210358D0 (en) * 2012-06-12 2012-07-25 Polytherics Ltd Complexes
FI3471760T3 (fi) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5130126A (en) * 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
JP3180106B2 (ja) * 1990-10-24 2001-06-25 株式会社三和化学研究所 有機高分子化合物の製造方法
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
CA2299117A1 (en) * 1999-02-24 2000-08-24 Stiefel Research Institute, Inc. Antimycotic compositions
EP1222217B1 (en) * 1999-09-08 2005-06-15 Polytherics Limited Uniform molecular weight polymers
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2002074247A2 (en) * 2001-03-19 2002-09-26 Praecis Pharmaceuticals Incorporated Pharmaceutical formulations for sustained release
BR0105500A (pt) * 2001-11-05 2004-06-22 Univ Minas Gerais Processo de obtenção de dispersões coloidais de anfotericina b; composições à base de anfotericina b de uso enteral, parenteral e tópico; uso destas composições no tratamento de micoses sistêmicas e infecções parasitárias

Similar Documents

Publication Publication Date Title
US8324333B2 (en) Anionic charge-dynamic polymers for release of cationic agents
JP6175451B2 (ja) ポリマー担体カーゴ複合体と少なくとも１つのタンパク質又はペプチド抗原とを含む医薬組成物
Lin et al. Enhanced immune responses to mucosa by functionalized chitosan-based composite nanoparticles as a vaccine adjuvant for intranasal delivery
Gambaryan et al. Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection
JP2019509339A5 (https=)
JP2012017342A5 (https=)
CA2637765A1 (en) Benzamide and heteroarene derivatives
JPWO2009041570A1 (ja) ステロイド類の高分子結合体
WO2021216467A1 (en) A nano-enabled vaccination approach for coronavirus disease (covid-19) and other viral diseases
Desai et al. Nanoadjuvants: promising bioinspired and biomimetic approaches in vaccine innovation
Yu et al. Quaternized chitosan nanoparticles in vaccine applications
Hsu et al. Polyphosphazenes for the delivery of biopharmaceuticals
CN112839674B (zh) 包含抗原肽-佐剂核苷酸缀合体的免疫诱导剂及包含其的药物组合物
Orosco et al. Navigating the landscape of adjuvants for subunit vaccines: recent advances and future perspectives
CA2840974A1 (en) Vaccine composition for mucosal administration
JP2007518732A5 (https=)
Akilesh M et al. Novel applications of nanotechnology in controlling HIV and HSV infections
CN101360514A (zh) 基于双酰氧基丙基半胱氨酸缀合物及其衍生物的新佐剂及其在药物组合物中的用途
Liu et al. Polymeric nanoparticles engineered as a vaccine adjuvant-delivery system
US20150024001A1 (en) Molecular mimic mucosal aids vaccine
EP1701741B1 (en) Complexes having adjuvant activity
JP2020182486A5 (https=)
JP6559898B2 (ja) スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物
JP2012526847A5 (https=)
JP4707107B2 (ja) ジシアロウンデカ糖鎖アスパラギン−脂肪酸アミド、これを含む医薬